Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

SIMPARICA TRIO DIN 02492660

Status: Marketed
Holder: ZOETIS CANADA INC
Molecule: SAROLANER

Health Canada record

Active ingredient(s)SAROLANER 6 MG; MOXIDECTIN 0.12 MG; PYRANTEL (PYRANTEL PAMOATE) 25 MG
Dosage formTablet (Chewable)
RouteOral
SchedulePRESCRIPTION
ClassVeterinary
ATC
Original market date23-Apr-2020
Current status date23-Apr-2020
SourceHealth Canada DPD

Establishment licence of the holder

Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing SAROLANER

DINProductCompanyFormStrengthStatus
02482266REVOLUTION PLUSZOETIS CANADA INCSolutionSAROLANER 10 MG; SELAMECTIN 60 MGMarketed
02452030SIMPARICAZOETIS CANADA INCTablet (Chewable)SAROLANER 20 MGMarketed
02452049SIMPARICAZOETIS CANADA INCTablet (Chewable)SAROLANER 40 MGMarketed
02452057SIMPARICAZOETIS CANADA INCTablet (Chewable)SAROLANER 80 MGMarketed
02452065SIMPARICAZOETIS CANADA INCTablet (Chewable)SAROLANER 120 MGMarketed
02452014SIMPARICAZOETIS CANADA INCTablet (Chewable)SAROLANER 5 MGMarketed
02452022SIMPARICAZOETIS CANADA INCTablet (Chewable)SAROLANER 10 MGMarketed
02492652SIMPARICA TRIOZOETIS CANADA INCTablet (Chewable)SAROLANER 3 MG; MOXIDECTIN 0.06 MG; PYRANTEL (PYRANTEL PAMOATE) 12.5 MGMarketed
02492679SIMPARICA TRIOZOETIS CANADA INCTablet (Chewable)SAROLANER 12 MG; MOXIDECTIN 0.24 MG; PYRANTEL (PYRANTEL PAMOATE) 50 MGMarketed
02492687SIMPARICA TRIOZOETIS CANADA INCTablet (Chewable)SAROLANER 24 MG; MOXIDECTIN 0.48 MG; PYRANTEL (PYRANTEL PAMOATE) 100 MGMarketed
02492695SIMPARICA TRIOZOETIS CANADA INCTablet (Chewable)SAROLANER 48 MG; MOXIDECTIN 0.96 MG; PYRANTEL (PYRANTEL PAMOATE) 200 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
361232025-10-07Supplement to a New Drug Submission (SNDS)Additional indication for the reduction of Dipylidum caninum infections via killing of the vector flea
336382024-07-16Supplement to a New Drug Submission (SNDS)Additional indication
313532023-08-02Supplement to a New Drug Submission (SNDS)Additional claims
281182022-05-10Supplement to a New Drug Submission (SNDS)ADDITIONAL INDICATIONS
227072019-09-26New Drug Submission (NDS)
Request a quote for SIMPARICA TRIO

How to read a Canadian DIN record